hepatocellular carcinoma phenotype

Aliases

HCC

No related entities found.

Mentioned in (38)

Papers in which this entity is mentioned.

• A guide to transcriptomic deconvolution in cancer. (2026)
• Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationships. (2026)
• Meta-analysis reveals differences in somatic alterations by genetic ancestry across common cancers. (2025)
• Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
• Chromosomal instability as a driver of cancer progression. (2025)
• Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology. (2024)
• The Application of Long-Read Sequencing to Cancer. (2024)
• Cell-Free DNA Fragmentomics: The Novel Promising Biomarker. (2023)
• Towards understandings of serine/arginine-rich splicing factors. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. (2022)
• At the dawn: cell-free DNA fragmentomics and gene regulation. (2022)
• Epigenetic analysis of cell-free DNA by fragmentomic profiling. (2022)
• Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. (2022)
• Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. (2021)
• Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer. (2021)
• Evaluating the transcriptional fidelity of cancer models. (2021)
• kataegis: an R package for identification and visualization of the genomic localized hypermutation regions using high-throughput sequencing. (2021)
• Macrophage Polarization States in the Tumor Microenvironment. (2021)
• Pan-cancer analysis of whole genomes. (2020)
• Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
• The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer. (2018)
• The Immune Landscape of Cancer. (2018)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
• SvABA: genome-wide detection of structural variants and indels by local assembly. (2018)
• Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. (2017)
• Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin. (2016)
• Fragment Length of Circulating Tumor DNA. (2016)
• Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
• Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. (2016)
• MBASED: allele-specific expression detection in cancer tissues and cell lines. (2014)
• CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. (2014)
• Signatures of mutational processes in human cancer. (2013)
• Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. (2013)
• Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. (2013)
• Absolute quantification of somatic DNA alterations in human cancer. (2012)
• Myeloid cells in tumor inflammation. (2012)
• GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. (2011)

Merged raw entities (1)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.